AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 251 min read$CBLL

Chao Xingjuan sold $146K of CBLL

Chao Xingjuan (President and CEO) sold 6,068 shares of Ceribell, Inc. (CBLL) at $24.02 ($0.15M total) on 2026-08-21.

Original reporting
SEC EDGAR · Chao Xingjuan
Published Aug 25, 2026, 11:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 11:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$CBLL
Neutral
high confidence
Mentioned
$CBLL
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBLLNeutralLow
01

Why it matters

The transaction is small relative to total holdings and unlikely to affect market perception.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential upcoming clinical data releases could outweigh the impact of this small insider sale.

Relevance 4/10Novelty 4/10Timing: post‑market filing on Aug 25

Background

Form 4 filings disclose insider transactions; this filing reports a routine sale by Ceribell's CEO.

Company-level read

Ticker impact

$CBLLNeutralHigh confidence
Context

CEO Chao Xingjuan sold 6,068 shares for $145,753 on Aug 21, lowering his stake to 781,731 shares.

Expected impact

minimal impact; price may stay flat or dip slightly on short‑term selling pressure.

Evidence & confidence

Insider sales under $200k from a CEO are routine and rarely signal material information.

Market effects

Sector

No significant effect on the medical‑device sector.

Regional

Limited to U.S. investors tracking insider activity.

Global

Negligible on a global scale.

Counterpoint

What could challenge this read

If the CEO is reallocating capital, the stock could be undervalued and present a buying opportunity.

Key entities

  • Company
    Ceribell, Inc.

    Medical‑device company listed on Nasdaq under CBLL.

  • Individual
    Chao Xingjuan

    President and CEO of Ceribell.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CBLL insider trading history →

Related articles

AUG 10
$CBLLHigh

Ceribell, Inc. (CBLL): Results of Operations and Financial Condition

Ceribell, Inc. (CBLL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ceribell Reports Second Quarter 2026 Financial Results Sunnyvale, Calif. – August 10, 2026 – CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today repor

SEC EDGAR 8-K6 min